EP3258934A4 - Soft gelatin capsules containing fexofenadine - Google Patents

Soft gelatin capsules containing fexofenadine Download PDF

Info

Publication number
EP3258934A4
EP3258934A4 EP16753099.7A EP16753099A EP3258934A4 EP 3258934 A4 EP3258934 A4 EP 3258934A4 EP 16753099 A EP16753099 A EP 16753099A EP 3258934 A4 EP3258934 A4 EP 3258934A4
Authority
EP
European Patent Office
Prior art keywords
gelatin capsules
soft gelatin
capsules containing
containing fexofenadine
fexofenadine
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
EP16753099.7A
Other languages
German (de)
English (en)
French (fr)
Other versions
EP3258934A1 (en
Inventor
Abdul Rashid
Dahai Guo
Minh Tran
Zhang Julia ZHANG
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Enspire Group LLC
Original Assignee
Enspire Group LLC
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US14/627,589 external-priority patent/US20160243044A1/en
Application filed by Enspire Group LLC filed Critical Enspire Group LLC
Publication of EP3258934A1 publication Critical patent/EP3258934A1/en
Publication of EP3258934A4 publication Critical patent/EP3258934A4/en
Withdrawn legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841—Filling excipients; Inactive ingredients
    • A61K9/4858—Organic compounds

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
EP16753099.7A 2015-02-20 2016-02-19 Soft gelatin capsules containing fexofenadine Withdrawn EP3258934A4 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US14/627,589 US20160243044A1 (en) 2015-02-20 2015-02-20 Soft gelatin capsules containing fexofenadine
US201562255615P 2015-11-16 2015-11-16
PCT/US2016/018574 WO2016134200A1 (en) 2015-02-20 2016-02-19 Soft gelatin capsules containing fexofenadine

Publications (2)

Publication Number Publication Date
EP3258934A1 EP3258934A1 (en) 2017-12-27
EP3258934A4 true EP3258934A4 (en) 2018-09-05

Family

ID=56692326

Family Applications (1)

Application Number Title Priority Date Filing Date
EP16753099.7A Withdrawn EP3258934A4 (en) 2015-02-20 2016-02-19 Soft gelatin capsules containing fexofenadine

Country Status (4)

Country Link
EP (1) EP3258934A4 (zh)
CN (1) CN107847496A (zh)
HK (1) HK1253053A1 (zh)
WO (1) WO2016134200A1 (zh)

Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1995023595A1 (en) * 1994-03-02 1995-09-08 The Procter & Gamble Company Concentrated acetaminophen solution compositions
US20120183608A1 (en) * 2011-01-14 2012-07-19 Enspire Group LLC Highly concentrated liquid acetaminophen solutions
US20140073670A1 (en) * 2011-05-20 2014-03-13 Aventis Pharmaceuticals Inc. Pharmaceutical composition comprising fexofenadine
WO2015003109A1 (en) * 2013-07-03 2015-01-08 R.P. Scherer Technologies, Llc Capsule formulation comprising fexofenadine
US20150108033A1 (en) * 2013-10-21 2015-04-23 Banner Life Sciences, LLC Pharmaceutical compositions for poorly soluble active ingredients

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6248363B1 (en) * 1999-11-23 2001-06-19 Lipocine, Inc. Solid carriers for improved delivery of active ingredients in pharmaceutical compositions
US20050266032A1 (en) * 2003-12-17 2005-12-01 Sovereign Pharmaceuticals, Ltd. Dosage form containing multiple drugs

Patent Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1995023595A1 (en) * 1994-03-02 1995-09-08 The Procter & Gamble Company Concentrated acetaminophen solution compositions
US20120183608A1 (en) * 2011-01-14 2012-07-19 Enspire Group LLC Highly concentrated liquid acetaminophen solutions
US20140073670A1 (en) * 2011-05-20 2014-03-13 Aventis Pharmaceuticals Inc. Pharmaceutical composition comprising fexofenadine
WO2015003109A1 (en) * 2013-07-03 2015-01-08 R.P. Scherer Technologies, Llc Capsule formulation comprising fexofenadine
US20150108033A1 (en) * 2013-10-21 2015-04-23 Banner Life Sciences, LLC Pharmaceutical compositions for poorly soluble active ingredients

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
See also references of WO2016134200A1 *

Also Published As

Publication number Publication date
CN107847496A (zh) 2018-03-27
HK1253053A1 (zh) 2019-06-06
EP3258934A1 (en) 2017-12-27
WO2016134200A1 (en) 2016-08-25

Similar Documents

Publication Publication Date Title
EP3273948A4 (en) Liquisoft capsules
EP3356449A4 (en) HYBRID CAPSULES
GB201510608D0 (en) Image data encapsulation
ZA201703444B (en) Calcifediol soft capsules
SG11201800376UA (en) Composition for soft capsule shell
GB201608157D0 (en) Capsules
EP3406237A4 (en) CASSETTE OF TABLETS
EP3173060A4 (en) Medicine cassette
GB201502666D0 (en) Image data encapsulation
EP3653203A4 (en) ENTERAL HARD CAPSULE
EP3254665A4 (en) Tablet cartridge
SG11201701972PA (en) Soft capsule shell
EP3332775A4 (en) ENTERIC CAPSULE
EP3338804A4 (en) ENTERIC CAPSULE
EP3329921A4 (en) TABLET
EP3100721A4 (en) Capsule formulation
EP3181125A4 (en) Capsule formulation
GB2559320B (en) Dual capsule tag
EP3393605A4 (en) OXYGEN-PRODUCING CAPSULE
EP2976985A4 (en) Capsule endoscope
EP3646864A4 (en) PEMAFIBRATE MEDICINAL PRODUCT
HK1253053A1 (zh) 含有非索非那丁的軟明膠膠囊
GB201911748D0 (en) Image data encapsulation
ZAA201801557S (en) Capsule
ZAA201801556S (en) Capsule

Legal Events

Date Code Title Description
PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

17P Request for examination filed

Effective date: 20170818

AK Designated contracting states

Kind code of ref document: A1

Designated state(s): AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR

AX Request for extension of the european patent

Extension state: BA ME

DAV Request for validation of the european patent (deleted)
DAX Request for extension of the european patent (deleted)
A4 Supplementary search report drawn up and despatched

Effective date: 20180808

RIC1 Information provided on ipc code assigned before grant

Ipc: A61K 31/4418 20060101AFI20180802BHEP

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN

18D Application deemed to be withdrawn

Effective date: 20190305